Chip Butty boosted
Wikidata boosted
Matthieu Viry and 1 other boosted
Chart: Est. & Reported U.S. Variant Proportions by Common Name
Sources: CDC, Cov-Lineages, NYITCOM, D. Focosi, WHN, others

[ beadsland on Ko-fi ]

Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.

Four bar-style tree-charts, for four-week periods through Oct 26–Nov 22. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.

Nearly all WHO-Vaccine-Target JN.1 dynasty. Stratus XFG family accounts for over four fifths share.

For 9/28–10/25, packed bubble charts fill single-variant tiles, reflecting GISAID detail not shown by CDC's Nowcast.

Legend:

XFG [reds]:
69% - XFG.2†, XFG.3†, XFG.3.4.1 / QF†, XFG.5.1†, XFG.4.1†, XFG.5.2†, XFG.3.4.3 / QS† & other Stratus XFG
10% - XFG.14.1
8% - XFG.1 & XFG.6

JN.1.11 [browns]:
9% - XFZ, XFV, NW.1 & FDA-Vaccine-Target LP.8.1
0% - other JN.1.11

JN.1 + FLiRT-LF-7 [blues]:
⅛% - LF.7.9
¼% - other LF.7

LF.7 + NTD-meets-RBD [purples]:
⅕% - XFC
0% - other LF.7 + NTD-meets-RBD

WHO-Vaccine-Target JN.1 [green]:
0% - XEC

Other [greys]:
4% - Nimbus NB.1.8.1 / PQ, XFY & XDV.1
⅓% - Other (not specified)
_____

XFC is a child of April's WHO-Vaccine-Target scion LF.7 and Mayish JN.1.11 scion LP.8.1.1 / NY.

XFZ is a child of left-field WHO-Vaccine-Target scion PG.3.2 and Augustish recombinant kid XFC.3.

[Some footnotes omitted, due to too many recombinants.]
Chart: Est. & Reported U.S. Variant Proportions by Common Name Sources: CDC, Cov-Lineages, NYITCOM, D. Focosi, WHN, others [ beadsland on Ko-fi ] Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC. Four bar-style tree-charts, for four-week periods through Oct 26–Nov 22. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart. Nearly all WHO-Vaccine-Target JN.1 dynasty. Stratus XFG family accounts for over four fifths share. For 9/28–10/25, packed bubble charts fill single-variant tiles, reflecting GISAID detail not shown by CDC's Nowcast. Legend: XFG [reds]: 69% - XFG.2†, XFG.3†, XFG.3.4.1 / QF†, XFG.5.1†, XFG.4.1†, XFG.5.2†, XFG.3.4.3 / QS† & other Stratus XFG 10% - XFG.14.1 8% - XFG.1 & XFG.6 JN.1.11 [browns]: 9% - XFZ, XFV, NW.1 & FDA-Vaccine-Target LP.8.1 0% - other JN.1.11 JN.1 + FLiRT-LF-7 [blues]: ⅛% - LF.7.9 ¼% - other LF.7 LF.7 + NTD-meets-RBD [purples]: ⅕% - XFC 0% - other LF.7 + NTD-meets-RBD WHO-Vaccine-Target JN.1 [green]: 0% - XEC Other [greys]: 4% - Nimbus NB.1.8.1 / PQ, XFY & XDV.1 ⅓% - Other (not specified) _____ XFC is a child of April's WHO-Vaccine-Target scion LF.7 and Mayish JN.1.11 scion LP.8.1.1 / NY. XFZ is a child of left-field WHO-Vaccine-Target scion PG.3.2 and Augustish recombinant kid XFC.3. [Some footnotes omitted, due to too many recombinants.]
Chart: Estimated and Reported U.S. Variant Proportions by Common Name
Sources: CDC, Cov-Lineages, NYITCOM, D. Focosi, WHN, others

[ beadsland on Ko-fi ]

Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.

Four bar-style tree-charts, for four-week periods through Oct 26–Nov 22. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.

Nearly all WHO-Vaccine-Target JN.1 dynasty. Stratus XFG family accounts for over four fifths share.

For 10/26–11/22, packed bubble charts fill single-variant tiles, indicating diversification (per GISAID) not apparent from CDC's Nowcast.

Legend:

XFG [reds]:
69% - XFG.2†, XFG.3†, XFG.3.4.1 / QF†, XFG.4.1† & other Stratus XFG
10% - XFG.14.1
8% - XFG.6, XFG.1.1† & other XFG.1

JN.1.11 [browns]:
9% - XFZ, XFV, NW.1 & FDA-Vaccine-Target LP.8.1
0% - other JN.1.11

JN.1 + FLiRT-LF-7 [blues]:
⅛% - LF.7.9
¼% - other LF.7

LF.7 + NTD-meets-RBD [purples]:
⅕% - XFC
0% - other LF.7 + NTD-meets-RBD

WHO-Vaccine-Target JN.1 [green]:
0% - XEC

Other [greys]:
4% - Nimbus NB.1.8.1 / PQ, XFY & XDV.1
⅓% - Other (not specified)
_____

XFC is a child of April's WHO-Vaccine-Target scion LF.7 and Mayish JN.1.11 scion LP.8.1.1 / NY.

XFZ is a child of left-field WHO-Vaccine-Target scion PG.3.2 and Augustish recombinant kid XFC.3.

[Some footnotes omitted, due to too many recombinants.]
Chart: Estimated and Reported U.S. Variant Proportions by Common Name Sources: CDC, Cov-Lineages, NYITCOM, D. Focosi, WHN, others [ beadsland on Ko-fi ] Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC. Four bar-style tree-charts, for four-week periods through Oct 26–Nov 22. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart. Nearly all WHO-Vaccine-Target JN.1 dynasty. Stratus XFG family accounts for over four fifths share. For 10/26–11/22, packed bubble charts fill single-variant tiles, indicating diversification (per GISAID) not apparent from CDC's Nowcast. Legend: XFG [reds]: 69% - XFG.2†, XFG.3†, XFG.3.4.1 / QF†, XFG.4.1† & other Stratus XFG 10% - XFG.14.1 8% - XFG.6, XFG.1.1† & other XFG.1 JN.1.11 [browns]: 9% - XFZ, XFV, NW.1 & FDA-Vaccine-Target LP.8.1 0% - other JN.1.11 JN.1 + FLiRT-LF-7 [blues]: ⅛% - LF.7.9 ¼% - other LF.7 LF.7 + NTD-meets-RBD [purples]: ⅕% - XFC 0% - other LF.7 + NTD-meets-RBD WHO-Vaccine-Target JN.1 [green]: 0% - XEC Other [greys]: 4% - Nimbus NB.1.8.1 / PQ, XFY & XDV.1 ⅓% - Other (not specified) _____ XFC is a child of April's WHO-Vaccine-Target scion LF.7 and Mayish JN.1.11 scion LP.8.1.1 / NY. XFZ is a child of left-field WHO-Vaccine-Target scion PG.3.2 and Augustish recombinant kid XFC.3. [Some footnotes omitted, due to too many recombinants.]
Chart: Estimates of Long Covid: Extrapolated to Entire U.S. Population
Data: Census Bureau, Nat'l Cntr for Health Stats, Dept of Health & Human Svcs, Bureau of Labor Stats (via FRED), CDC

[ beadsland on Ko-fi ]

Line chart, from Apr 2022 to date, of:

• Ever Experienced Long Covid for 3+ Months (61M as of Sep '24)
• Reported Staffed Hospital Beds (2.1K per Million) [Was 2.3K Apr '22]
• Population 16+ With a Disability — Labor Stats (35.1M) [Apr '22: 32.7M]
• Now Living with LC (18.1M)
• Current Activity Limitations from LC (15M)
• Significant Limitations (4.4M)

Caption (in part):

Household Pulse Survey (HPS)…an Internet questionnaire…by…Census Bureau…includes questions regarding “any symptoms lasting 3 months or longer that you did not have prior to having coronavirus or COVID-19.” [Note] that the list of long-term symptoms, provided for this question, may not reflect all sequelae of covid infection, e.g., systemic organ damage or increased susceptibility to subsequent infections and other adverse health outcomes.

NCHS uses HPS responses to estimate incidence of [LC] in adult population. With [retraction & new studies] now assume U.S. under 18 population (22% of total) meet criteria for [LC] at same rate as adults.

Census…was due to relaunch Household Pulse Survey (HPS) as Household Trends and Outlook Pulse Survey (HTOPS)…January 2025….had been no relaunch as of [Jan 20].…now is word of a general moratorium on…executive branch agencies communicating with the public…."
Chart: Estimates of Long Covid: Extrapolated to Entire U.S. Population Data: Census Bureau, Nat'l Cntr for Health Stats, Dept of Health & Human Svcs, Bureau of Labor Stats (via FRED), CDC [ beadsland on Ko-fi ] Line chart, from Apr 2022 to date, of: • Ever Experienced Long Covid for 3+ Months (61M as of Sep '24) • Reported Staffed Hospital Beds (2.1K per Million) [Was 2.3K Apr '22] • Population 16+ With a Disability — Labor Stats (35.1M) [Apr '22: 32.7M] • Now Living with LC (18.1M) • Current Activity Limitations from LC (15M) • Significant Limitations (4.4M) Caption (in part): Household Pulse Survey (HPS)…an Internet questionnaire…by…Census Bureau…includes questions regarding “any symptoms lasting 3 months or longer that you did not have prior to having coronavirus or COVID-19.” [Note] that the list of long-term symptoms, provided for this question, may not reflect all sequelae of covid infection, e.g., systemic organ damage or increased susceptibility to subsequent infections and other adverse health outcomes. NCHS uses HPS responses to estimate incidence of [LC] in adult population. With [retraction & new studies] now assume U.S. under 18 population (22% of total) meet criteria for [LC] at same rate as adults. Census…was due to relaunch Household Pulse Survey (HPS) as Household Trends and Outlook Pulse Survey (HTOPS)…January 2025….had been no relaunch as of [Jan 20].…now is word of a general moratorium on…executive branch agencies communicating with the public…."
Chart: Est. & Reported U.S. Variant Proportions by Common Name
Sources: CDC, Cov-Lineages, NYITCOM, D. Focosi, WHN, others

[ beadsland on Ko-fi ]

Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.

Four bar-style tree-charts, for four-week periods through Oct 26–Nov 22. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.

Nearly all WHO-Vaccine-Target JN.1 dynasty. Stratus XFG family accounts for over four fifths share.

For 9/28–10/25, packed bubble charts fill single-variant tiles, reflecting GISAID detail not shown by CDC's Nowcast.

Legend:

XFG [reds]:
69% - XFG.2†, XFG.3†, XFG.3.4.1 / QF†, XFG.5.1†, XFG.4.1†, XFG.5.2†, XFG.3.4.3 / QS† & other Stratus XFG
10% - XFG.14.1
8% - XFG.1 & XFG.6

JN.1.11 [browns]:
9% - XFZ, XFV, NW.1 & FDA-Vaccine-Target LP.8.1
0% - other JN.1.11

JN.1 + FLiRT-LF-7 [blues]:
⅛% - LF.7.9
¼% - other LF.7

LF.7 + NTD-meets-RBD [purples]:
⅕% - XFC
0% - other LF.7 + NTD-meets-RBD

WHO-Vaccine-Target JN.1 [green]:
0% - XEC

Other [greys]:
4% - Nimbus NB.1.8.1 / PQ, XFY & XDV.1
⅓% - Other (not specified)
_____

XFC is a child of April's WHO-Vaccine-Target scion LF.7 and Mayish JN.1.11 scion LP.8.1.1 / NY.

XFZ is a child of left-field WHO-Vaccine-Target scion PG.3.2 and Augustish recombinant kid XFC.3.

[Some footnotes omitted, due to too many recombinants.]
Chart: Est. & Reported U.S. Variant Proportions by Common Name Sources: CDC, Cov-Lineages, NYITCOM, D. Focosi, WHN, others [ beadsland on Ko-fi ] Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC. Four bar-style tree-charts, for four-week periods through Oct 26–Nov 22. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart. Nearly all WHO-Vaccine-Target JN.1 dynasty. Stratus XFG family accounts for over four fifths share. For 9/28–10/25, packed bubble charts fill single-variant tiles, reflecting GISAID detail not shown by CDC's Nowcast. Legend: XFG [reds]: 69% - XFG.2†, XFG.3†, XFG.3.4.1 / QF†, XFG.5.1†, XFG.4.1†, XFG.5.2†, XFG.3.4.3 / QS† & other Stratus XFG 10% - XFG.14.1 8% - XFG.1 & XFG.6 JN.1.11 [browns]: 9% - XFZ, XFV, NW.1 & FDA-Vaccine-Target LP.8.1 0% - other JN.1.11 JN.1 + FLiRT-LF-7 [blues]: ⅛% - LF.7.9 ¼% - other LF.7 LF.7 + NTD-meets-RBD [purples]: ⅕% - XFC 0% - other LF.7 + NTD-meets-RBD WHO-Vaccine-Target JN.1 [green]: 0% - XEC Other [greys]: 4% - Nimbus NB.1.8.1 / PQ, XFY & XDV.1 ⅓% - Other (not specified) _____ XFC is a child of April's WHO-Vaccine-Target scion LF.7 and Mayish JN.1.11 scion LP.8.1.1 / NY. XFZ is a child of left-field WHO-Vaccine-Target scion PG.3.2 and Augustish recombinant kid XFC.3. [Some footnotes omitted, due to too many recombinants.]